McKesson FY2026 EPS Estimate Increased by Leerink Partnrs

McKesson Corporation (NYSE:MCK) – Equities researchers at Leerink Partnrs lifted their FY2026 earnings per share estimates for shares of McKesson in a report issued on Thursday, November 6th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $38.77 per share for the year, up from their prior estimate of $38.35. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s Q4 2026 earnings at $11.48 EPS, FY2027 earnings at $44.04 EPS, FY2028 earnings at $49.82 EPS and FY2029 earnings at $56.46 EPS.

MCK has been the subject of a number of other reports. Morgan Stanley boosted their price target on shares of McKesson from $857.00 to $916.00 and gave the company an “overweight” rating in a research report on Thursday. JPMorgan Chase & Co. lifted their price objective on McKesson from $821.00 to $853.00 and gave the company an “overweight” rating in a research note on Friday, September 26th. Deutsche Bank Aktiengesellschaft raised their price target on McKesson from $775.00 to $856.00 and gave the company a “buy” rating in a report on Wednesday, September 24th. Wells Fargo & Company boosted their price objective on McKesson from $772.00 to $816.00 and gave the stock an “equal weight” rating in a report on Wednesday, September 24th. Finally, Cowen reaffirmed a “buy” rating on shares of McKesson in a research note on Wednesday, September 24th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, McKesson has an average rating of “Moderate Buy” and a consensus price target of $880.15.

McKesson Trading Down 0.9%

Shares of NYSE:MCK opened at $850.77 on Friday. The company has a 50 day moving average of $757.54 and a 200 day moving average of $724.05. The stock has a market cap of $105.82 billion, a P/E ratio of 33.92, a P/E/G ratio of 1.46 and a beta of 0.51. McKesson has a 12 month low of $558.13 and a 12 month high of $867.63.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share for the quarter, beating the consensus estimate of $8.84 by $1.02. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The firm had revenue of $103.15 billion for the quarter, compared to analysts’ expectations of $103.80 billion. During the same period in the prior year, the business posted $7.07 earnings per share. The company’s revenue was up 10.2% on a year-over-year basis.

Hedge Funds Weigh In On McKesson

Large investors have recently added to or reduced their stakes in the business. IAM Advisory LLC grew its stake in shares of McKesson by 0.3% during the third quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after buying an additional 13 shares during the last quarter. PDS Planning Inc grew its position in McKesson by 1.1% during the 3rd quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock worth $934,000 after acquiring an additional 13 shares during the last quarter. Berkshire Asset Management LLC PA increased its stake in McKesson by 4.6% in the 3rd quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock worth $227,000 after purchasing an additional 13 shares during the period. MassMutual Private Wealth & Trust FSB lifted its position in McKesson by 1.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 863 shares of the company’s stock valued at $632,000 after purchasing an additional 14 shares during the last quarter. Finally, Cardinal Point Capital Management ULC boosted its stake in shares of McKesson by 2.2% during the second quarter. Cardinal Point Capital Management ULC now owns 645 shares of the company’s stock valued at $473,000 after purchasing an additional 14 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other McKesson news, CEO Brian S. Tyler sold 11,930 shares of McKesson stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the transaction, the chief executive officer directly owned 4,012 shares of the company’s stock, valued at approximately $2,830,987.56. This trade represents a 74.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.08% of the stock is owned by insiders.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is currently 10.21%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.